2025 VBEF Future Healthcare & Pharma Top 100 Expo: At the Inflection Point of Innovation
Over the past year, participants in China’s healthcare industry have demonstrated through their actions the survival principle of “THE NOW”:
In 2024, 48 domestically developed Class 1 new drugs emerged, setting a record high; license-out transaction volume and value continued to surpass inbound deals, signaling the transformation of China’s pharmaceutical industry in the global arena. In the medical device sector, 66 innovative medical devices received regulatory approval, with 37 recognized as “first-of-their-kind,” reflecting a 56% rate of original innovation and marking China’s medical technology leap from “follower” to “leader.”
Every fluorescence microscope in the laboratory is documenting the dormant energy being amassed by innovators; behind every set of clinical trial data surges the quantum leap of disruptive breakthroughs. This is the "critical moment" for China’s medical professionals—within the seemingly silent depths of the industry, countless micrometer-scale innovative potentials are accumulating, ultimately converging into a mighty wave that will reshape the global healthcare landscape.
The 2025 VBEF Future Healthcare & Pharma Top 100 Exhibition, themed “THE NOW: Tipping Point,” is organized by VCBeat and will be grandly held at the Suzhou International Expo Center from May 9 to 10, 2025.
Now in its eighth edition, VBEF centers on innovative showcases and deep connectivity, featuring five core segments: “Forums + Awards + Exhibitions + Reports + Resource Matchmaking.” It continuously provides new channel expansion opportunities for innovative products and delivers ecosystem collaboration value to various institutions through investment and financing, business development (BD) partnerships, supply chain transactions, and overseas expansion.
Seizing the opportunity presented by the release of the 2025 Future Healthcare Top 100 rankings, VBEF brings together the most dynamic innovative enterprises, high-growth companies, industry leaders, medical institutions, financial capital, and upstream and downstream supply chain partners from both China and abroad. It provides a comprehensive overview of the year’s new technologies, products, services, resources, business opportunities, and ecosystems, gradually establishing its brand identity as “Look for Innovation, Seek Collaboration, Turn to VBEF.” As a result, it has become a bellwether for industry investment, business development (BD), and market collaborations in the current year and for the foreseeable future.
• Authoritative Rankings Released, Frontline Trend Analysis:2025 Future Healthcare Top 100 Selection: Identifying the True Core Forces; 2 Main Forums Focusing on Trend Strategy and Innovation, 4 Featured Forums Analyzing Cutting-Edge Technologies and Market Trends, 20+ Thematic Forums Discussing Hot Topics to Uncover New Opportunities in the Future of Healthcare, with 300+ Industry Leaders Sharing Their Insights!
• Global Collaboration, Direct Trading via Supply Chain Partnerships:Featuring eight themed exhibition zones, the event facilitates direct face-to-face dialogues with over 2,000 medical device manufacturers, pharmaceutical companies, supply chain enterprises, and distributors/agents from more than 20 countries and regions, enabling efficient exploration of business collaboration and transaction opportunities!
• High-Value Resources, Efficient Connections:15,000 sqm exhibition space, 150+ exhibitors, on-site debut of 400+ innovative products, alongside N+ networking activities including matchmaking sessions, closed-door meetings, and project roadshows—diverse events enabling efficient and precise matchmaking and collaboration!
Swipe down to view the list of confirmed attendees (partial)
Swipe down to view the (partial) list of attending/exhibiting companies
(Proposed schedule; specific forums and session times are subject to on-site arrangements)
May 9, 09:00-17:00
★ Forum News
● Gao Guobiao |The Party Secretary and Deputy Director of the Center for Medical Device Evaluation, formerly under the China Food and Drug Administration, has confirmed attendance;
● Zhao Guoping | Academician of the Chinese Academy of SciencesConfirm attendance;
● Xu Shuqiang | Former Director of the Department of System Reform, National Health Commission; Chair Professor, Shanghai Jiao Tong University; Dean, China Hospital Development Institute
● Yuan Xin | Director of the Center for Aging Development Strategy Research at Nankai University, Vice President of the China Population Association
● Cai Daqing | Founding Partner, Sherpa Capital
● Li Li | President of Aier Eye Hospital Confirms Attendance;
● Tu Zhiliang, Chairman of Gushengtang, Confirmed to Attend;
● Zhang Ling | Senior Technical Expert at the DAMO Academy Medical AI Lab and Head of Multi-Cancer Screening Technology, confirmed to attend;
● Li Datao, Founder of VCBeat, Confirmed to Attend;
Trend Tipping Point: Interpreting Shifts in the Macro Tide
▸ Conference Address
▸The Technological Tipping Point: From Geography to Spatial Possibilities
▸Tipping Point for Systemic Reshaping: Insights into Opportunities from Structural Changes in the Healthcare System
▸The Tipping Point in Payment Reform: Cost Containment in Medical Insurance and the Evolution of the Healthcare Payment System
▸Demographic Shifts: Changing Industry Demands in an Aging Society
▸Unlocking the Global Potential of Healthcare Innovation: Reshaping Health Equity Through Technology and Collaboration
▸Expert Dialogue: The Tipping Point of the Private Healthcare System and Market Development Amidst New Industrial Transformation
Tipping Point of Trends: Interpreting the Direction of Industrial Innovation
▸ Development Opportunities in the Integration of Medicine and Engineering: Innovation in Translational Practice
▸ Dialogue with Industry Leaders: Envisioning an Ecosystem for Original Innovation
▸ Intelligent Healthcare: Innovative Applications of Large AI Models in the Medical Field
▸ Core Technological Innovation: Driving Global Expansion and Win-Win Outcomes
▸ Breaking the Monopoly: The Path to Domestic Production of High-End Medical Devices
▸ The Rise of Domestic Medical Devices: A Leap from Substitution to Innovation
▸ Dialogue with Industry Leaders: Innovation Opportunities and Challenges in the Medical Device Supply Chain
May 10, 09:00-17:00
★Forum Flash
● Lu Gang | Partner at Legend Star, confirmed to attend;
● Ding Zhaoliang (Dang Gui) | Founder and CEO of Knowledge Matrix Confirmed to Attend;
● Fei Jianjiang | Managing Partner at Yuanhe Origin Confirmed to Attend;
● Wang Xun | Chief Investment Officer of Huagai Capital confirms attendance;
● Jinghua Wang | Managing Partner, Medtronic China Fund Confirmed to Attend;
● Wang Junfeng, Co-Chief Investment Officer of Legend Capital, Confirmed to Attend;
● Wang Zhixing, President of Wuxi Innovation Investment Group Co., Ltd., has confirmed his attendance;
● Shen Sheng | Director, Investment Banking Department, Haitong Securities, confirmed to attend;
● Zhao Dongyue, Co-founder and Vice President of Huangfeng Capital, confirmed to attend;
● Liu Tingting | Partner at AllBright Law Offices confirmed to attend;
● Pivotal bioVenture、Ping An Health,Jones Lang LaSalle,China Association of Medical EquipmentConfirm attendance at the forum;
Excellent Solutions at the Tipping Point: A New Corporate Strategy
▸ The Next Frontier in Digital Healthcare: Greater Precision, Higher Efficiency, and Broader Accessibility
▸ Digital Investment Strategy: From Cost Reduction and Efficiency Enhancement to Value Creation
▸ Internet Healthcare: Content Marketing Ushers in a New Chapter for the Industry
▸ Spatial Innovation: A Forward Look at Next-Generation Healthcare Environments
▸ Strategic Transformation and Industrial Ecosystem Reshaping Amid the M&A Wave
▸ Expert Dialogue: Investment Opportunities in Healthy China Development Under the New Landscape
Development Opportunities at the Tipping Point: Globalization Strategy
▸ Opportunities and Challenges for the Internationalization of China’s Medical Device Industry in the New Landscape
▸ Pathways and Strategies for Chinese Enterprises Going Global—UN Procurement
▸ The Storm of the EU MDR’s New Regulations: How Can Chinese Medical Device Companies Cross the Life-or-Death Line of Compliance?
▸ Breaking Through to Build a New Ecosystem for Cross-Border Financial Services
▸ From “Price Wars” to “Brand Wars”: The Path to Breakthrough in Localized Operations for Emerging Markets
▸ From Offshoring Production Capacity to Offshoring Supply Chains: The “Resilience Revolution” Launched by the Medical Device Industry
▸ Expert Dialogue: Practices, Opportunities, and Challenges in Cross-Border Business Development for Medical Devices
Co-hosted by: Enshe Capital
May 9, 09:00-17:00
★Forum News
● Enshe Capital co-organized this forum as a joint host;
● Jingyuan Li, Chief Technology Officer of MathWorks China, confirmed to attend;
Breakthrough Innovations in Core CT Components in China: A Perspective from Global Trends in Medical Imaging Innovation
▸ Collaborative Innovation through Medical-Engineering Integration: Enhancing Quality and Accelerating R&D of Medical Devices
▸ Empowering the upstream sector of medical imaging devices to build a new industrial ecosystem
▸ CT Detector Technology Ushers in a New Era of High-Resolution Imaging
▸Breakthroughs and Innovations in CT X-ray Tube Technology
▸ Foundational Considerations on the Investment Logic for Medical Device Design and Manufacturing
▸ Roundtable Discussion: Independent R&D and Manufacturing of Medical Devices Amid New Opportunities
Leading Chinese Medical Imaging Manufacturers Drive Supply Chain Innovation: Continuous Innovation and Upgrading of Core Components
▸ The Path to Original Innovation Driven by New Quality Productive Forces
▸ Innovative Technologies Drive the Development of Medical Imaging
▸ Innovative Sensing Technology Drives the Upgrade of Medical Devices
▸ The Path to Domestic Production of High-End Ultrasound Transducers
▸ Independent R&D and Manufacturing of Medical Devices Amid New Opportunities
The Value and Creation of Third-Party Roles in the Medical Device Design and Manufacturing Industry Chain
▸ From Incubation to Investment: Driving Upstream Innovation in the Medical Device Industry at Its Source
▸Empowering the Innovative Development of China’s Domestic Medical Imaging Industry
▸ Tackling the “chokehold” challenges in medical imaging equipment at their source
May 10, 09:00–12:00
★ Forum Flash News
● Chen Tao, Chairman of Dongmai Medical Group, confirmed to attend;
● Jingyuan Li, Chief Technology Officer of MathWorks China, confirmed to attend;
The Emergence of Source Innovation in the Context of Medical-Engineering Integration
▸ R&D Innovation—The Path to Translating Medical-Engineering Innovations into Practical Applications
▸ Key Elements and Pathways for Source Innovation in Medical Devices
▸ CDMO Empowers the Integration of Medicine and Engineering
▸ Regulatory Trends Under the High-Quality Development of China’s Medical Device Regulation
▸ Bridging the innovation and translation chain to build a new ecosystem for medical-engineering translation
▸ Roundtable Discussion: Synergistic Challenges and Opportunities in Early-Stage Design and Clinical Development, as Well as Source Innovation and Manufacturing
The Iterative Upgrading and Diversified Development of China’s Domestic Supply Chain Propels Its Rise as a Core Force in the Global Medical Technology Manufacturing and Innovation Chain
▸The Path to Win-Win Cooperation Between MNCs and China’s Medical Device Industry Chain
▸ Synergy in the Medical Device Industry Chain Under Domestic Innovation
▸ Pathways for Innovation and Breakthrough in Future Medical Device Categories
▸ Synergistic Development of Source Innovation and Manufacturing from a CXO Perspective
▸AI and Big Data-Driven Transformation of Intelligent Manufacturing in Medical Devices
▸ Breaking Through: A Strategic Guide for Chinese Medical Device Companies to Enter the Global Market
▸ Practices and Reflections on Cost Reduction and Efficiency Enhancement in Response to Centralized Procurement
▸ Roundtable Discussion: Focus on Medical Devices—The Battle for Supply Chain Security, Cost Reduction and Efficiency Enhancement under Volume-Based Procurement, and the Code to Domestic Substitution
May 9, 09:00-17:00
Release of Global Industry Innovation Trends
▸ Report on the Innovation Ecosystem of the Global Biomanufacturing Industry Released
▸ Preview of the Global Innovation Ranking for the Biomanufacturing Industry
▸ Inauguration Ceremony of the Global Biomanufacturing Industry Innovation Consortium
▸ Signing Ceremony for Key Project Collaboration
▸ Industrial Applications of Genetic Engineering: The Path to Innovation from Enzymes to Pharmaceuticals
▸ Unlocking a New Era of Convergent Development in Life Sciences
▸ Biomanufacturing and Human Nutrition
▸ Synthetic Biology Engineering of Microbial Resources: Ushering in a New Era of Biomanufacturing
▸ From Lab to Market: Key Points in the Industrialization of Biotechnology
▸ Discovery of Intracellular Metabolic Pathways and Industrialization of Synthetic Biology
▸ Applications of Industrial Biotechnology in the Biofuels and Chemicals Sector
Global Industry Hotspots and International Cooperation Matchmaking
▸ Sharing DuPont’s Global Development Experience
▸ Analysis of Localization Strategies by Global Enzyme Giants
▸ From Global Chemical Giant to Pioneer in Biomanufacturing
▸ BASF’s Practices in the Field of Biomanufacturing
▸ Reflections on DBN’s Global Layout in Biomanufacturing
▸ Revelations from the Wave of U.S. Biomanufacturing
▸DNA Synthesis Platforms Fuel the Takeoff of the Global Biomanufacturing Industry
▸ Global Trends in Biomanufacturing Venture Capital Investment
▸ VCBeat Select · Innovative Product Showcase
May 10, 09:00–17:00
Blockbuster Product Analysis and Leading Enterprise Strategy Launch
▸“1 Acid + 2 Factors”: How to Capture Half of the Cosmetic Ingredients Market
▸Recombinant Collagen: A 20-Year Formula for Anti-Aging
▸Pro-Xylane: How to Deliver Strong Cost-Performance in Hardcore Anti-Aging?
▸Biocomputing Ushers in a New Era of Biomanufacturing
▸AI + Biomanufacturing Empowers the Cosmetics Industry’s Renewal and Upgrading
▸VCBeat Select · Innovative Product Showcase & Distributor Matchmaking
Innovation Project Roadshow and Launch of High-Potential Candidates
▸ Achieving the Chemically Impossible: How to Trigger the Tipping Point for HMOs
▸“The King of Immunity” PQQ: How to Choose the First Commercialization Entry Point
▸Discovering Meta-Proteins: The Future of Third-Pole Food Is Here
▸Replacing Collagen: The Next Generation of Anti-Aging Makes Its Debut
▸The Future of Bio-based Materials
▸VCBeat Select · Innovative Product Showcase & Distributor Matchmaking
Co-organized by: Guoke Hengtai
May 9, 09:00–12:00
★ Forum Flash News
● Co-organized by Guoke Hengtai as a joint organizer;
● Cao Jinci, General Manager of the Marketing Shared Service Platform for Distribution Channels at Guoke Hengtai, has confirmed his attendance;
● Wang Zewei, Head of the Strategic Cooperation and Investment Department at Guoke Hengtai, has confirmed his attendance;
● Liu Shaohua, Marketing Manager at Guoke Hengxing, has confirmed his attendance;
● Liu Tianyi, Head of the CDMO Shared Manufacturing Department at Guoke Hengtai, confirmed to attend;
● Chao Daidi, Head of the Logistics Planning Department at Guoke Hengtai, has confirmed attendance;
● Zhu Yichen, CEO of Yijiada, confirmed to attend;
Factory Tour
Innovative Model
Empowering Distributors, Winning Together in the New Era
VBInsight Leaders
Product Launch
Empowering the Future
▸ Empowering Innovative Medical Devices, Collaborating for Joint Creation and Investment
▸ Digitalization Promotes High-Quality Compliance Development Under New Circulation Regulations
▸ End-to-End CDMO + Shared Service Platform Boosts Efficiency and Accelerates Growth in the Medical Device Industry Chain
▸ Sinopharm Hengtai Shared Logistics Services: Third-Party Logistics by Sinopharm Hengtai, Empowering Business Growth
Expert Insights
VBEF Innovative Product Roadshow
May 10, 09:00-17:00
★ Forum News
● Sun Yuewu | Chairman of the Committee, China Association for Promotion of Healthy Development of Pharmaceutical Industry, has confirmed his attendance;
● Prof. Duan Tao | Shanghai First Maternity and Infant Hospital Confirmed to Attend;
● Yin Yuehan, Executive Director of Hengxu Capital, confirmed to attend;
● Dong Qing, Vice President of the Drug Marketing Department at Hua Medicine, confirmed to attend;
● Li Jing, Founder and CEO of Fanzhuo Group, Confirmed to Attend;
● Wu Yinsong, Founder and Chairman of Xiushi Biopharmaceutical (Nantong) Co., Ltd., confirmed to attend;
● Dong Qing, Vice President of the Drug Marketing Department at Hua Medicine, has confirmed his attendance;
New Channels
▸ Interpretation of the Latest Policies in the Out-of-Hospital Market and Analysis of Product Opportunities
▸ M&A Wave in Consumer Healthcare: A Multiplier Engine for Performance Growth
▸ Patient-Centric: Reshaping the New Ecosystem of Pharmaceutical Retail
▸ Ceremony Segment 1: Inauguration Ceremony for the Online Channel Innovation Organization
▸ Ceremony Segment 2: Launch Ceremony of the Cancer Survivor Rehabilitation Rally, etc.
▸ Leverage the Power of Content to Build High-Virality Healthcare and Medical Traffic IPs
▸ E-commerce Driven: How to Achieve N-fold Growth for Pharmaceutical and Medical Device Brands and Operations
▸ Investment Strategies and Business Growth Logic for Foods for Special Medical Purposes (FSMP)
▸ How Private Domain Operations Empower Growth in Healthcare Businesses
▸ Roundtable Discussion: Innovative Breakthroughs and Transformative Opportunities in Aesthetic Medicine Ingredients
New Business
▸ Decoding the Compliance Rules of Healthcare Marketing Ads
▸ Potential and Opportunities in the Instant Retail and Pharmaceutical O2O Markets
▸ Old Bottles, New Wine: DTP Pharmacies Emerge as a Key Channel for the Launch and Promotion of Innovative Drugs
▸ The Breakout Rules for Home Medical Devices: Traffic Wave-Making Techniques in E-commerce Marketing
▸ Unlocking the Secrets of Public and Private Domain Traffic to Reshape the Marketing Ecosystem of the Health Checkup Industry
▸ How to Build a Full-Lifecycle Supply Chain Service for Pharmaceuticals and Medical Devices
▸ From Traffic Anxiety to User Assets: Upgrading Customer Acquisition Mindset in the Dental Industry
▸ Roundtable Discussion: All Roads Lead to “C”: Exploring Opportunities and Practical Strategies for Multi-Category Products in the Out-of-Hospital Market
May 9, 09:00-12:00
★ Forum Flash News
● Deng Bin | Co-founder of Taozi HealthConfirm Attendance;
● Zong Wenhong, CEO of Xikang Cloud Hospital, confirmed to attend;
Construction Achievements
▸ Innovation and Challenges Behind the Development of Internet Hospitals
▸ Achievements and Reflections on the Construction of Smart Hospitals at National Regional Medical Centers
Innovative Exploration
▸ Smart Healthcare Practices on Internet Medical Platforms
▸ Reflections and Explorations on Digital Healthcare Internet Product Platforms
▸ Innovative Development and Operational Practices of Internet Nursing Platforms
▸ Practices and Explorations in the Construction of a Big Data Management and Control Platform for Scientific Research
Opportunities and Challenges
▸ Roundtable Discussion: Opportunities and Challenges in the Development of Internet Hospitals and Smart Hospitals
May 9, 09:00–12:00
★ Forum News Flash
● Zhao Yu (Mai Dong) | Vice President of Knowledge Matrix and Head of the Healthcare DivisionConfirm attendance;
Grasping Trends in Pharmaceutical Marketing
▸ Practical Implementation and Development Trends of Digitalization in Pharmaceutical Marketing
Pharmaceutical Companies' Innovative Exploration
▸Pharmaceutical New Retail Strategy
▸How AI Becomes a Strategic Force in Pharmaceutical R&D and Marketing
▸ Strategic Marketing Advantages of Differentiated Targets
▸ Direct-to-Patient Pharmaceutical Marketing
▸ Digital Empowerment Boosts the Marketing of Traditional Chinese Medicine
▸ Riding the Wave of Innovative Drugs: Expanding Global Marketing
Platform Empowers Precision Marketing
▸ Omnichannel Population-Based Pharmaceutical Marketing in the Digital Age
▸ The Dual Flywheel Effect Drives Value Realization for All Stakeholders
▸ Provision of Digital and Intelligent Tools Amid the Digitalization Wave in Pharmaceutical Companies
▸ Digital Marketing Tools and Applications in the Pharmaceutical Industry
New Trends in Digital Marketing
▸ Roundtable Discussion: New Trends in Digital Marketing
Co-organized by: ATLATL Innovation Center
May 9, 14:00-17:00
★ Forum News Flash
● The ATLATL Dart Innovation Center co-organized this forum as a joint host;
● Zhu Pengcheng, Founder of ATLATL Innovation R&D Center, Confirmed to Attend;
Clinical Perspective
▸ AI-Empowered Drug Discovery: The Path from Laboratory to Clinical Translation
▸ Regulatory Science Development in AI-Driven Drug Discovery
Industrial Empowerment
▸ Digital Transformation and Asset-Light Models in Biopharmaceutical R&D / Cross-Border Collaborative Innovation Between Biotechnology and Information Technology
▸Capital Opportunities and Challenges in AI-Driven Drug Discovery: Investment Strategies and Future Trends
Industrial Chain Perspective
▸ AI-Empowered Proteomics Research: From Structure Prediction to Functional Exploration
▸ AI-Driven Drug Discovery and Design
▸ Roundtable Discussion: The Tool Revolution—Technological Innovation, Regulatory Challenges, and Industry Ecosystem Development
May 9, 14:00–17:00
★ Forum Flash News
● Shen Li | Secretary-General of the China Cardiovascular Physicians Innovation Club (CCI), Chief Physician in the Department of Cardiology, Zhongshan Hospital Affiliated to Fudan University
● Gu Leimin, Partner at Yuansheng Venture Capital, Confirmed to Attend;
● Peng Huiqun, Founder and CEO of Puchuang Medical, confirmed to attend;
● Li Yingjun | General Manager of Tonghe Litai confirms attendance;
Keynote Address
▸ Breaking Boundaries · Integration · Win-Win: Exploring the Clinical-Driven Model of Cardiovascular Innovation
▸ How Cardiovascular Device Companies Can Crack the Commercialization Challenge
▸ “Report on Ablation Technologies and Market Trends” Released
▸ Industry Giants Increase Investment and Domestic Innovation Rise: PFA to Dominate Cardiac Ablation Technology in the Next Decade
▸ Technological Innovation: Making Healthcare More Precise and Efficient
▸How CROs Empower Rapid Regulatory Approval of Domestically Produced Innovative Cardiovascular Devices
Roundtable Discussion
▸ The Evolutionary Path, Opportunities, and Challenges of Cardiovascular Devices
May 10, 09:00-12:00
★ Forum News Flash
● Sun Xiaoyu | Vice President of Information Technology, Medtronic Greater China, Confirmed to Attend;
● Wang Rong | Vice President of Eli Lilly China/Head of Eli Lilly China Innovation Collaboration Center confirmed to attend;
● AstraZeneca confirms attendance at the forum;
Benchmark Practices
▸ From Data to Insights: Pfizer’s Digital-Driven Healthcare Innovation
▸ Building Digital Healthcare in China's Ecosystem
▸ Digital Intelligence-Driven: AstraZeneca’s Practices in Digital Innovation and Ecosystem Building
▸ From Devices to Ecosystem: Digital-Driven Industry Transformation by Siemens Healthineers
▸ Patient-Centered Digital Ecosystem: From Disease Management to Full Lifecycle Services
Ecological Empowerment
▸ Expert Dialogue: Opportunities and Challenges in Co-building a Digital Ecosystem
May 10, 09:00–12:00
★ Forum Flash News
● Yu Rong | Chairman of Meinian Onehealth Healthcare Group confirmed to attend;
● Xu Bingyu, CEO of Huamei Haolian, Confirmed to Attend;
● Wang Jun | Co-founder of Weimei Health Confirmed to Attend;
● Bohe Innovation Center confirms attendance at the forum;
Perspective of Ecological Co-Creation
▸ AI Engine × Big Data: Decoding Meinian’s New Paradigm for AI-Driven Health Management
▸ Exploring the Boundaries of Medical AI Applications to Co-build an Integrated Diagnosis and Treatment Innovation Ecosystem
Application Scenario Perspective
▸ Open-sourcing large language models drives the intelligent upgrade of solutions and products across the entire healthcare industry
▸AI-Empowered Community Hospitals: Enhancing Quality, Reducing Costs, and Boosting Efficiency
▸ AI-Empowered Primary Healthcare: Large Language Models Usher in a New Paradigm for Smart County-Level Medical Care
▸ Release of the White Paper: "New Quality Productive Forces: Integrated Innovation Practices of Large Models in Healthcare Scenarios"
▸ Generative AI Services Propel Life Sciences Innovation into a New Era
▸ Expert Dialogue: Pathways for Collaborative and Innovative Development in the AI Industry Amidst New Technologies, Concepts, and Landscapes
May 10, 09:00–12:00
★ Forum Flash News
● Professor Liao Hongen, Tenured Professor at Tsinghua University, confirmed to attend;
● Zhou Guanshan, Director of the Strategic Development Department at Kangji Medical, has confirmed his attendance;
● Zhang Xiaonong, Founder of Aoruiji Medical, Confirmed to Attend;
● Liu Xiaowei, General Manager of Deneng Medicine, has confirmed attendance;
● Zhu Yichen, CEO of Yijiada, confirmed to attend;
● Jin Rong | Chief Marketing Officer of Yilu Kuaijian confirmed to attend;
Keynote Address
▸ Integrated Intelligent Minimally Invasive Diagnosis and Treatment: AI-Driven Technological Innovation
▸ Kangji Medical: The Rise of Chinese-Made Minimally Invasive Surgery (Tentative)
▸ Unlocking the Potential of Novel Biodegradable Absorbable Metal Materials in Minimally Invasive Surgery
▸ A Window of Opportunity Opens! How Can China’s Laparoscopic Surgical Robots Further Achieve Domestic Innovation?
▸ Surviving the Shakeout: How Can Domestic Ultrasonic Scalpel Manufacturers Navigate the “Life-or-Death” Challenge?
▸ A New Investment Perspective in the Field of Minimally Invasive Surgical Instruments: Technological Innovation, Market Trends, and Long-Term Value Creation
Roundtable Discussion
▸ The Path of Transformation, Opportunities, and Challenges in the Minimally Invasive Surgery Industry
Co-organized by: VBInsight New Medicine
May 10, 09:00-17:00
VCBeat Dynamics & Innovation in Focus
▸ Overview of Full Lifecycle Management for Innovative Drugs and CGT Trends
▸ A Global Perspective: Reflections on the Transformation of Fundamental Investment Logic in China’s CGT Sector
▸Panel 1: New Strategies in CGT—Hotspots, Dilemmas, and Breakthroughs
▸ New Technologies Drive the Upgrade of CGT Products
▸ Panel 2: New RNA Strategies—Hotspots, Dilemmas, and Breakthroughs
▸ Panel 3: Insights on Investment and Financing—Experience Shared by Industry Veterans
Transformation Awakening
▸ Shifting Mindsets and Pathways in Drug Development: From Laboratory to Clinic
▸ Commercialization and Incubation of Scientific Research Achievements to Boost the Development of the CGT Industry
▸ Empowering Early-Stage Innovation, Realizing Entrepreneurial Dreams
▸ Panel 4: Collaboration on Outcome Translation and Ecosystem Building
BD Breakthrough
▸ Product Perspective: First Look at New BD Opportunities, Then at CGT
▸ Panel 5: CGT Global Expansion—Product Export and Supply Chain Internationalization
▸ Panel 6: The Buyer’s Perspective—BD Collaboration Models and Success Stories
May 10, 14:00–17:00
★ Forum Flash News
● Geng Jia | Deputy Director of the Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, confirmed to attend;
● Liang Zhikun, Deputy Director of the Research Institute at Da An Gene, has confirmed his attendance;
● Liu Xiaowei, General Manager of Deneng Medical, confirms attendance;
Clinical Perspective
▸ Single-Molecule Biosensing Technology and Innovative Diagnostics
Industrial Chain Perspective
▸ Development and Application of Molecular Tumor Diagnostics and Personalized Therapy
▸ Frontier Trends in Liquid Biopsy Technology: Personalized Panels Facilitate Stratified Diagnosis and Treatment of MRD, Improving Quality of Life for Cancer Patients
▸Policy Differences Between LDTs and IVDs and Pathways for Conversion
▸ Advances in Genetic Testing Technologies and Their Clinical Applications
▸ Innovations and Breakthroughs in the Field of Breath Analysis
Ecological Perspective
▸ Roundtable Discussion: Opportunities and Challenges in Precision Diagnosis and Treatment
May 10, 14:00-17:00
★Forum Flash News
● Huang Yanli, Director of the Science and Information Department at Chengdu Wuhou District Hospital Management Service Center, Confirmed to Attend；
● Wang Xu, General Manager of the Medical Health Management Department of Sunshine Insurance Group, has confirmed his attendance;
● Cai Zhuo | Head of ZhongAn Internet Hospital, ZhongAn Insurance, Confirmed to Attend;
● Xing Jing, Founder of Shangyong Technology, Confirmed to Attend;
● Song Yiran, Founder of Shanghai Yishu Health, Confirmed to Attend;
● Wang Bei, Investment Director of Pacific Insurance, confirmed to attend;
● Ping An Health confirms attendance at the forum;
Integrated Innovation
▸ How Was the “Wuhou Model” of Integrating Health Management with Health Insurance Formed Through Multi-Pronged Initiatives?
▸ Expanding the Insured Population: What Further Exploration Opportunities Exist for Health Insurance Covering Individuals with Pre-existing Conditions?
Health Insurance Innovation
▸ New Trends in the Synergistic Development of Healthcare and Insurance in an Aging Society
▸ Building an “Insurance + Healthcare” Closed Loop to Lead a New Paradigm in Health Management
▸ Focusing on the Frontier: How AI is Reshaping Health Management and Creating New Opportunities for the Development of Health Insurance?
Innovation in Health Management
▸ Data-Driven, Precision Pricing: Reshaping the Health Insurance Value Chain
▸ How Technology Empowers Health Management: Leveraging Digital Intelligence to Drive Personalized and Refined Development
Integration and Innovation
▸ Roundtable Discussion: Innovation and Development Opportunities in Health Management and the Health Insurance Industry
Co-organized by: He Eye Hospital
May 10, 14:00–17:00
★ Forum Flash News
● He Eye Hospital, as a co-organizer, jointly created this forum;
● Wang Yingqi, CEO & Co-founder of TopEye Medical, confirmed to attend;
● He Eye Hospital confirms attendance at the forum;
Innovative Development of AI in Ophthalmology
▸ Partnering with Artificial Intelligence to Comprehensively Build an Eye Health Ecosystem Management System
▸ The Rise of the “Hundred-Scope War”: Four Major Ophthalmology Segments Take Off (Draft)
▸ Five Major Opportunities for Ophthalmic Gene Therapy Amidst the “Hundred-Model War” (Proposed)
▸ Pioneering AR Freeform Optics Technology, Eye Health Management Enters the Era of Far-View Imaging
▸ Roundtable Discussion: Opportunities and Challenges for Ophthalmology in the New Wave of Artificial Intelligence
Innovative Development of High-End Ophthalmic Devices
▸ Report Release: "Research Report on the Localization Process of High-End Ophthalmic Equipment"
▸ After Breaking Through Technological Barriers, Chinese-Made High-End Imaging Devices Go Global and Reap Lucrative Profits
▸ Leveraging Early Diagnosis of Glaucoma to Drive Innovation and Development in Domestically Produced Ophthalmic Devices
▸ Breaking the Import Monopoly: Chinese Companies Enter the SMILE Laser Surgery Market
▸ Domestic and Overseas Enterprises Advance Side by Side; Ophthalmic Surgical Robotics Innovation Still Needs to Overcome Three Hurdles
▸ Roundtable Discussion: Domestic Substitution and Innovation in High-End Medical Devices?
(More forums and agenda details will be updated gradually)
(Click to view the full-size image)
May 09 Medical Device Distributor Conference
May 9-10 Medical Device Design and Manufacturing Conference
May 09-10 Global Bio-Manufacturing Conference
May 10: Conference on Growth in New Business and New Channels for the Out-of-Hospital Market
Internet Hospital and Smart Hospital Forum, Pharmaceutical Company Digital Marketing Forum, Medical AI Large Model Application Innovation Forum, ITBT & AI Drug R&D Forum, Cardiovascular Disease Industry-Research Innovation Forum, Foreign Enterprise Digital Innovation and Development Forum, Medical AI Large Model Scenario Application Forum, Minimally Invasive Surgery Industry Innovation and Development Forum, CGT Venture Capital and BD New Opportunities Forum, Precision Medicine and Molecular Diagnostics Industry Development Forum, Health Management and Health Insurance Development Forum, Ophthalmology Industry Innovation and Development Forum...
More forums to be updated
2025 Future Healthcare Top 100 List Release Ceremony and Innovation Awards Ceremony
Matchmaking sessions, closed-door meetings, project roadshows, high-end business events, etc.
★Themed Exhibition Area★
Innovative Medical Device Product Exhibition, Medical Device Design and Manufacturing Exhibition, Digital Healthcare and Services Exhibition,
Biomanufacturing Thematic Exhibition, Life Science Instrumentation Exhibition, Health Consumer Products Collection Exhibition,
Regional Government Park Exhibition, International Exhibition Area... More themed exhibition areas to be updated
[Click to Register] 2025 Top 100 Future Healthcare Companies Selection
Exhibition Name:2025 VBEF Future Healthcare & Pharma Top 100 Exhibition
Exhibition Time:May 9–10, 2025
Exhibition Venue:China · Suzhou · International Expo Center
Exhibition Scale:16,000+ patient visits
(More partners are being confirmed; please stay tuned to VBEF for the latest updates.)
Organizer:VCBeat
Co-hosted by:VCBeat New Medicine, ATLATL Dart Innovation Center, Enshe Capital, Guoke Hengtai, He Eye Hospital, Tan Zhen Capital
Forum Supporting Organizations:MathWorks, Pivotal BioVenture, Alibaba DAMO Academy, Anjieming, Aoruiji, Bohe Innovation Center, Boson Quantum, Deneng Medicine, Dongmai Medical, Enshe Capital, Fanzhuo Group, Guotai Junan, Hunan Medical Device Industrial Park, He Eye Specialist Hospital, Huamei Haolian, Hengxu Capital, Jinghan New Materials, Jieshi Medical, Lulutong Health, Linsheng Polymer, Legend Star, Ping An Health, Puchuang Medical, Ruisen Medical, Shangyong Technology, Taozi Health, Tonghe Litai, TopEye Medical, Xiyi Medicine, Xikang Cloud Hospital, Yishu Health, Yanyin Technology, Yijiada Medical, Jones Lang LaSalle, Zhejiang Kayi, Knowledge Matrix
Supported Industrial Parks:Changping Life Valley Industrial Base, Optics Valley Bio-City/Wuhan Gaoke Medical Device Park, Jiangsu Medical Device Science and Technology Industrial Park, Zhongguancun (Tongzhou) Innovative Medical Translation Industrial Park (Yifang Health Valley)
Exhibition Support Media:21st Century Business Herald, E-Pharma Academy, MedWorld Device World, Bioon Valley, Touch Biology, Cyzone, Big Health Pie, Hao De Ya, Huihui Pharmacist, CN-Healthcare, Jixiao 361, Kuaisu Wenyisheng, Bioon, Taidu TIMEDOO, Tansi Biotech, Zero2IPO, Xiao Fan Zhuo, Xinxi Xia, Yao Fangzhou, Yaoka Hui, Yaozhi Network, Medical Engineering Scholars, Yi Qianyan, DXY, Pharmaceutical Manager, Zhiyi Xun
